abstract
Zoetis Inc., a 2013 spin-off of Pfizer, focuses on the event, manufacture and advertising and marketing of animal well being vaccines and medicines, together with parasiticides, anti-infectives and medical feed components. The corporate develops merchandise for each livestock and companion animals, and distributes its merchandise globally. Zoetis is an S&P 500 part and has roughly 13,800 workers.
Subscribe to Yahoo Finance Plus Important for full entry
Unique experiences, detailed firm profiles, and best-in-class enterprise insights to take your portfolio to the following stage.
(Tags for translation)401k